Stage IVB Oropharyngeal Squamous Cell Carcinoma Recruiting Phase 1 Trials for Berzosertib (DB11794)

IndicationStatusPhase
DBCOND0039586 (Stage IVB Oropharyngeal Squamous Cell Carcinoma)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs